Skip to main content
CivicGate

S 1157
Passed Senate Re-checks Congress.gov for new actions and updates the bill's status, and fills in any sponsors, committees, or related bills that are missing. It does not re-pull sponsors/cosponsors/committees/related — those rarely change — and it skips all work if nothing has changed upstream, so it's cheap to click.

Women and Lung Cancer Research and Preventive Services Act of 2025

Introduced Mar 26, 2025

Latest action (Jun 9, 2026) Held at the desk.

Summary

  • Directs the Secretary of Health and Human Services, in consultation with the Secretaries of Defense and Veterans Affairs, to review and update federal lung cancer programs, activities, and strategic plans.
  • Sets the review's goals as identifying and addressing knowledge gaps and improving health outcomes for lung cancer in women and in populations with few known risk factors, and improving screening rates among populations recommended for screening by the U.S. Preventive Services Task Force.
  • Requires the review to cover existing federally funded research, consider interagency and multidisciplinary research opportunities, including environmental and genomic factors and biomarker testing, and assess current screening and diagnosis strategies and public awareness needs.
  • Requires the Secretary to submit a report to the Senate and House health and appropriations committees within 2 years of enactment, summarizing findings and any changes made to federal programs.
  • Requires the report to also identify any recommended additional program changes and any statutory or other barriers that impede them.

AI-generated plain-language summary of the bill text — neutral, and may be imperfect. See the full text below for the exact wording.

Sponsor (1)

7 cosponsors

Actions (10)

  1. Jun 9, 2026 Held at the desk. · house
  2. Jun 9, 2026 Received in the House. · house
  3. Jun 9, 2026 Message on Senate action sent to the House. · senate
  4. Jun 8, 2026 Passed Senate with an amendment by Unanimous Consent. (consideration: CR S2669-2670; text: CR S2669-2670) · senate
  5. Jun 8, 2026 Passed/agreed to in Senate: Passed Senate with an amendment by Unanimous Consent.
  6. Jan 28, 2026 Placed on Senate Legislative Calendar under General Orders. Calendar No. 308. · senate
  7. Jan 28, 2026 Committee on Health, Education, Labor, and Pensions. Reported by Senator Cassidy with an amendment in the nature of a substitute. Without written report. · senate
  8. Jan 15, 2026 Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably. · senate
  9. Mar 26, 2025 Read twice and referred to the Committee on Health, Education, Labor, and Pensions. · senate
  10. Mar 26, 2025 Introduced in Senate

Full text

AN ACT

To direct the Secretary of Health and Human Services to conduct a review to evaluate the status of research on lung cancer in women and underserved populations, and for other purposes.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

This Act may be cited as the “Women and Lung Cancer Research and Preventive Services Act of 2025”.

SEC. 2. INTERAGENCY REVIEW TO EVALUATE AND IDENTIFY OPPORTUNITIES TO IMPROVE LUNG CANCER PREVENTION AND TREATMENT IN WOMEN.

(a) In General.—The Secretary of Health and Human Services, in consultation with the Secretary of Defense and the Secretary of Veterans Affairs, shall review and, as necessary and appropriate, update Federal programs, activities, and strategic plans related to lung cancer research, prevention, diagnosis, and treatment for purposes of—

(1) identifying and addressing knowledge gaps and improving health outcomes related to lung cancer in women and populations with few known risk factors; and

(2) improving lung cancer screening rates among populations recommended by the United States Preventive Services Task Force to receive such screening.

(b) Content.—The review under subsection (a) shall include—

(1) a review of findings from research on lung cancer in populations described in paragraphs (1) and (2) of subsection

(a), the status of ongoing federally funded research on lung cancer in such populations, and knowledge gaps related to lung cancer in such populations;

(2) consideration of additional research opportunities, including through interagency collaboration and multidisciplinary projects, that would—

(A) eliminate knowledge gaps in research on lung cancer in women, including an evaluation of any environmental and genomic factors that may be related to the etiology of lung cancer in women;

(B) improve screening rates among populations described in subsection (a)(2); or

(C) foster advances in technology and interventions, including biomarker testing, to improve lung cancer risk assessment, diagnosis, and treatment; and

(3) a review of current public health strategies, and consideration of alternative evidence-based strategies, related to lung cancer screening and diagnosis, including an assessment of the need for additional public awareness and education.

(c) Report.—Not later than 2 years after the date of the enactment of this Act, the Secretary of Health and Human Services shall submit to the Committee on Health, Education, Labor, and Pensions and the Committee on Appropriations of the Senate and the Committee on Energy and Commerce and the Committee on Appropriations of the House of Representatives a report on the review conducted under subsection (a), including—

(1) a summary of research findings, ongoing research projects, and knowledge gaps described in subsection (b)(1);

(2) a description of any changes made by such Secretary or the head of any other Federal agency to Federal programs, activities, or strategic plans based on the findings of the review; and

(3) any additional changes to Federal programs, activities, or strategic plans recommended by the Secretary based on the review, and any statutory or other barriers that impede implementation of such changes.

Passed the Senate June 8, 2026.

Attest:

Secretary. 119th CONGRESS

2d Session

S. 1157

AN ACT

To direct the Secretary of Health and Human Services to conduct a review to evaluate the status of research on lung cancer in women and underserved populations, and for other purposes.

Text versions (3)

  • Engrossed in Senate · Jun 8, 2026
  • Reported to Senate · Jan 28, 2026
  • Introduced in Senate · Mar 26, 2025

More bills on these subjects (8)

Other bills that carry the most legislative subjects in common with this one (topical discovery — distinct from the procedural related bills above).

Comments

Comments

Loading comments…